Coming Changes in the US Diabetes Device Market
—A Complimentary Webinar from Millennium Research Group
The US diabetes market will grow, as the number of obese and diabetic patients grows.
But there are certain market segments that will show much stronger growth, including glucose monitoring (CGM) devices, insulin pumps and pens. Unlike most of the world, the US market has long favored syringes. Will this situation be changing?
Large competitors are diversifying their offerings in this market, and significant changes in market shares are likely.
What changes will this market see over the next five years?
Please join us for an in-depth analysis of this market within the context of our new reports:
US Markets for Diabetes Care Devices 2013
US Markets for Infusion Pumps 2013
Request more information about this webinar.
Our Analyst, Sean Messenger, will cover the following topics:
- Why are syringes still used more often than pens?
- What are the trends in this market, and where will it be in five years?
- How will the emergence of insulin pumps affect the market?
- What are the prospects for the development of an artificial pancreas?
Coming Changes in the US Diabetes Device Market
Register for MRG’s COMPLIMENTARY webinar.
The webinar will take place on February 13, 2013 at 11:00 am US Eastern Time, 8 am US Pacific Time, 5 pm Central European Time (Paris).
Aline Nouh | +1 (416) 364-7776 x392 | anouh@mrg.net
Webinar Details Date & Time Duration: 25 minutes |
About the Speaker Sean Messenger is an analyst in MRG’s cardiovascular division, where he has covered markets for minimally invasive devices, including diabetes care devices, transcatheter embolization devices, and nonvascular interventional radiology devices. Sean holds a B.Sc from the University of Waterloo’s Science and Business program, where he specialized in biotechnology and minored in economics. |
Terms of Use | Privacy Policy | Contact Us | Careers
Millennium Research Group • 175 Bloor Street East, South Tower Suite 400 • Toronto, CANADA M4W 3R8
© Millennium Research Group, Inc. All rights reserved.
